ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Specialist

Top Specialist Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KATHERINE KATSOYANNIS M.D.

Specialist

24,278

$1.56M

669
618 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

18%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 28%

$64
Average prescription price

Avg: $88

PANDELIS BANIAS PHD., M.D.

Specialist

18,958

$1.1M

560
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$58
Average prescription price

Avg: $88

RAKESH MARWAHA M.D.

Specialist

18,621

$1.23M

587
447 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$66
Average prescription price

Avg: $88

YATIN SHAH M.D.

Specialist

15,910

$864K

664
288 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$54
Average prescription price

Avg: $88

BARRY RAPAPORT M.D.

Specialist

14,811

$681K

390
141 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $88

PATRICIA STRINGER MD

Specialist

14,401

$792K

690
641 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$55
Average prescription price

Avg: $88

KEITH MOSS M.D.

Specialist

12,369

$787K

509
465 are 65+

2%
patients receiving schedule two controlled substances

Avg: 2%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$64
Average prescription price

Avg: $88

RAMALINGAPPA MUKUNDA M.D.

Specialist

10,772

$499K

198
143 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

20%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $88

ADRIAN DEME MD

Specialist

10,765

$797K

427
405 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 28%

$74
Average prescription price

Avg: $88

DANIEL PALMER MD

Specialist

9,583

$442K

412
241 are 65+

4%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $88

VATHIAR TAZUDEEN M.D.

Specialist

8,692

$998K

461
150 are 65+

10%
patients receiving schedule two controlled substances

Avg: 2%

45%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 28%

$115
Average prescription price

Avg: $88

ROBERT ANDINA M.D.

Specialist

8,210

$429K

346
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 28%

$52
Average prescription price

Avg: $88

RODNEY BERGER M.D.

Specialist

7,965

$302K

226
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$38
Average prescription price

Avg: $88

JAANA AVRAMIDIS M.D.

Specialist

7,308

$387K

335
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $88

RENE VASQUEZ M.D.

Specialist

7,093

$374K

339
273 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $88

V REDDY MD

Specialist

6,925

$316K

442
395 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 28%

$46
Average prescription price

Avg: $88

JAMES FAIRBAIRN M.D.

Specialist

6,520

$279K

228
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

26%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $88

AMY WASCHULL MD

Specialist

6,235

$266K

232
192 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 28%

$43
Average prescription price

Avg: $88

BRUCE CARLSON MD

Specialist

6,172

$372K

510
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

6%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 28%

$60
Average prescription price

Avg: $88

ALAN KOGAN M.D.

Specialist

6,135

$505K

428
409 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 28%

$82
Average prescription price

Avg: $88

CESAR YU M.D.

Specialist

6,085

$431K

219
164 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$71
Average prescription price

Avg: $88

PARAMJIT SIKAND M.D.

Specialist

5,899

$313K

286
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 28%

$53
Average prescription price

Avg: $88

DAVID KUO D.O

Specialist

5,808

$277K

128
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 28%

$48
Average prescription price

Avg: $88

MONZER KADDOUR M.D.

Specialist

5,658

$388K

236
214 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

19%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $88

JOSE CALUB MD

Specialist

5,643

$233K

201
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

27%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 28%

$41
Average prescription price

Avg: $88

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank